Compounds of formula (I) are described, wherein each of the variable groups is as defined in the specification. Also described are pharmaceutical compositions containing a compound of formula (I), and uses of the compounds and pharmaceutical compositions for inhibiting Nav1.8 voltage-gated sodium channels and treating Nav1.8 mediated diseases, disorders, and conditions, such as pain and pain-associated diseases, disorders, and conditions and cardiovascular diseases, disorders, and conditions.(I)
描述了式(I)的化合物,其中每个可变基团的定义如规范中所述。还描述了含有式(I)化合物的制药组合物,以及用于抑制Nav1.8电压门控
钠通道和治疗Nav1.8介导的疾病、紊乱和病症,如疼痛和与疼痛相关的疾病、紊乱和病症以及心血管疾病、紊乱和病症的化合物和制药组合物的用途。(I)